Search Results - "Theeten, H"

High frequency ultrasound to assess skin thickness in healthy adults by Van Mulder, T.J.S, de Koeijer, M, Theeten, H, Willems, D, Van Damme, P, Demolder, M, De Meyer, G, Beyers, K.C.L, Vankerckhoven, V

“…Abstract Background Intradermal immunization is gaining increased attention due to multiple factors: (1) intradermal (ID) vaccination has been shown to induce…”
Get full text

Skin thickness measurements for optimal intradermal injections in children by Van Mulder, T.J.S., Van Nuffel, D., Demolder, M., De Meyer, G., Moens, S., Beyers, K.C.L., Vankerckhoven, V.V.J., Van Damme, P., Theeten, H.

“…In the context of precision medicine and in response to the highly needed capacity of rapid interventions towards new infectious diseases and pandemic…”
Get full text

Immunogenicity and safety of intradermal delivery of hepatitis B booster vaccine using the novel drug delivery device VAX-ID by Van Mulder, T.J.S, Withanage, K, Beyers, K.C.L, Vankerckhoven, V.V.J, Theeten, H, Van Damme, P

“…AbstractBackgroundAlthough intramuscular (IM) injection is still the most preferred method for vaccination, intradermal (ID) delivery may have several…”
Get full text

Can Flanders resist the measles outbreak? Assessing vaccination coverage in different age groups among Flemish residents by Braeckman, T., Theeten, H., Roelants, M., Blaizot, S., Hoppenbrouwers, K., Maertens, K., Van Damme, P., Vandermeulen, C.

“…The Belgian strategic plan to eliminate measles contains several vaccination strategies including routine immunisation programmes and catch-up campaigns. A new…”
Get full text

Susceptibility to measles, mumps, and rubella in 5-year-old children in Flanders, Belgium by Leuridan, E., Maertens, K., Wautier, M., Hutse, V., Theeten, H.

“…The second dose of an MMR vaccine is a catch up for persons who did not receive the first dose or for primary vaccine failures. Catch up doses can be scheduled…”
Get full text

The seroprevalence of cytomegalovirus infection in Belgium anno 2002 and 2006: a comparative analysis with hepatitis A virus seroprevalence by Smit, G S A, Abrams, S, Dorny, P, Speybroeck, N, Devleesschauwer, B, Hutse, V, Jansens, H, Theeten, H, Beutels, P, Hens, N

“…Cytomegalovirus (CMV) infection is endemic worldwide but its seroprevalence varies widely. The goal of this study was to estimate the age-specific…”
Get full text

Seroepidemiology of mumps in Europe (1996–2008): why do outbreaks occur in highly vaccinated populations? by ERIKSEN, J., DAVIDKIN, I., KAFATOS, G., ANDREWS, N., BARBARA, C., COHEN, D., DUKS, A., GRISKEVICIUS, A., JOHANSEN, K., BARTHA, K., KRIZ, B., MITIS, G., MOSSONG, J., NARDONE, A., O'FLANAGAN, D., DE ORY, F., PISTOL, A., THEETEN, H., PROSENC, K., SLACIKOVA, M., PEBODY, R.

“…Mumps outbreaks have recently been recorded in a number of highly vaccinated populations. We related seroprevalence, epidemiological and vaccination data from…”
Get full text

Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium by THEETEN, H., HUTSE, V., HENS, N., YAVUZ, Y., HOPPENBROUWERS, K., BEUTELS, P., VRANCKX, R., VAN DAMME, P.

“…Susceptibility to vaccine-preventable diseases in Belgium in 2006 was estimated from a serum survey. Immunoglobulins against measles, mumps, rubella (MMR) and…”
Get full text

Assessing the risk of measles resurgence in a highly vaccinated population: Belgium anno 2013 by Hens, N, Abrams, S, Santermans, E, Theeten, H, Goeyvaerts, N, Lernout, T, Leuridan, E, Van Kerckhove, K, Goossens, H, Van Damme, P, Beutels, P

“…Despite long-standing two-dose measles-mumps-rubella (MMR) vaccination, measles outbreaks still occur in highly vaccinated European populations. For instance,…”
Get full text

Rotavirus vaccination coverage and adherence to recommended age among infants in Flanders (Belgium) in 2012 by Braeckman, T, Theeten, H, Lernout, T, Hens, N, Roelants, M, Hoppenbrouwers, K, Van Damme, P

“…In Belgium, rotavirus vaccination has been recommended and partially reimbursed since October 2006. Through a retrospective survey in 2012, we estimated the…”
Get full text

Universal hepatitis B vaccination in Belgium: impact on serological markers 3 and 7 years after implementation by THEETEN, H., HUTSE, V., HOPPENBROUWERS, K., BEUTELS, P., VAN DAMME, P.

“…Hepatitis B virus (HBV) can be eliminated by effective universal vaccination. In Belgium, a free-of-charge HBV vaccination programme in infants with catch-up…”
Get full text

EuSANH workshop “Reasons behind the differences in national vaccination schedules for under-five”, European Public Health pre-conference workshop, Malta, 8 November 2012 by Theeten, H, Nohynek, H, Coenen, T.M.M

“…Abstract Vaccination schedules for under-five children in the EU member states differ markedly, mainly as a consequence of differences in programme…”
Get full text

A comparison of hepatitis B seroepidemiology in ten European countries by NARDONE, A., ANASTASSOPOULOU, C. G., THEETEN, H., KRIZ, B., DAVIDKIN, I., THIERFELDER, W., O'FLANAGAN, D., BRUZZONE, B., MOSSONG, J., BOOT, H. J., BUTUR, D., SLAČIKOVÁ, M., PANAIT, M. L. C., HELLENBRAND, W., DE MELKER, H., SOBOTOVÁ, Z., ICARDI, G., ANDREWS, N., PEBODY, R. G., VAN DAMME, P., KAFATOS, G., MILLER, E., HATZAKIS, A.

“…To inform current and future vaccination strategies, we describe the seroepidemiology of hepatitis B virus (HBV) infection in ten representative European…”
Get full text

Modelling multisera data: The estimation of new joint and conditional epidemiological parameters by Hens, N., Aerts, M., Shkedy, Z., Theeten, H., Van Damme, P., Beutels, Ph

“…Testing humans for infectious diseases is often done by assessing the presence or absence of disease‐specific antibodies in serum samples. For feasibility and…”
Get full text

Effects of lowering the aluminium content of a dTpa vaccine on its immunogenicity and reactogenicity when given as a booster to adolescents by Theeten, H., Van Damme, P., Hoppenbrouwers, K., Vandermeulen, C., Leback, E., Sokal, E.M., Wolter, J., Schuerman, L.

“…As aluminium in vaccines has been associated with the incidence of local side effects occurring after vaccination, this observer-blind randomised clinical…”
Get full text

Should Europe have a universal hepatitis B vaccination programme? by Damme, Pierre Van, Leuridan, Elke, Hendrickx, Greet, Vorsters, Alex, Theeten, Heidi, Leino, Tuija, Salminen, Mika, Kuusi, Markku

“…WHO recommends that hepatitis B virus should be included in childhood vaccination programmes. Pierre Van Damme and colleagues argue that universal immunisation…”
Get full text

Model selection methodology for inter-laboratory standardisation of antibody titres by Kafatos, George, Andrews, Nick, Nardone, Anthony

“…The aim of the European Sero-Epidemiology Network 2 (ESEN2) is to compare standardised serological results of vaccine preventable diseases across Europe. In…”
Get full text

Reduced-Antigen Combined Diphtheria-Tetanus-Acellular Pertussis Vaccine (Boostrix???): A Viewpoint by Pierre Van Damme, Marie Van der Wielen and Heidi Theeten by Van Damme, Pierre, Van der Wielen, Marie, Theeten, Heidi

Get full text